{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:31Z","timestamp":1792131091630,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"crossref","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hereditary spastic paraplegia (HSP) is a group of inherited disorders characterized by progressive spastic paresis of the lower limbs. Treatment is often focused on reducing spasticity and its physical consequences. To better address individual patients\u2019 needs, we investigated a broad range of experienced complaints, activity limitations, and loss of motor capacities in pure HSP. In addition, we aimed to identify patient characteristics that are associated with increased fall risk and\/or reduced walking capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed and distributed an HSP-specific online questionnaire in the Netherlands. A total of 109 out of 166 questionnaires returned by participants with pure HSP were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants experienced the greatest burden from muscle stiffness and limited standing and walking activities, while 72% reported leg and\/or back pain. Thirty-five and 46% reported to use walking aids (e.g. crutches) indoors and outdoors, respectively; 57% reported a fall incidence of at least twice a year (\u2018fallers\u2019); in 51% a fall had led to an injury at least once; and 73% reported fear of falling. Duration of spasticity and incapacity to rise from the floor were positively associated with being a \u2018faller\u2019, whereas non-neurological comorbidity and wheelchair use were negatively associated. Higher age, experienced gait problems, not being able to stand for 10\u2009min, and incapacity to open a heavy door showed a negative association with being a \u2018walker without aids\u2019 (&gt;\u2009500\u2009m).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results emphasize the large impact of spastic paraparesis on the lives of people with pure HSP and contribute to a better understanding of possible targets for rehabilitation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-1338-4","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T12:02:57Z","timestamp":1583323377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6609-8782","authenticated-orcid":false,"given":"Bas J. H.","family":"van Lith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans C. J. W.","family":"Kerstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A. C.","family":"van den Bemd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria W. G. Nijhuis-van","family":"der Sanden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Weerdesteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J. E. M.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Fheodoroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P. C.","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C. H.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"issue":"4","key":"1338_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1055\/s-2008-1041143","volume":"13","author":"AE Harding","year":"1993","unstructured":"Harding AE. Hereditary spastic paraplegias. Semin Neurol. 1993;13(4):333\u20136.","journal-title":"Semin Neurol"},{"issue":"12","key":"1338_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127\u201338.","journal-title":"Lancet Neurol"},{"issue":"8334","key":"1338_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1(8334):1151\u20135.","journal-title":"Lancet."},{"key":"1338_CR4","volume-title":"Hereditary Spastic Paraplegia Overview","author":"JK Fink","year":"1993","unstructured":"Fink JK. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, LJH B, et al., editors. Hereditary Spastic Paraplegia Overview. Seattle (WA): GeneReviews(R); 1993."},{"issue":"8","key":"1338_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/archneur.60.8.1045","volume":"60","author":"JK Fink","year":"2003","unstructured":"Fink JK. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol. 2003;60(8):1045\u20139.","journal-title":"Arch Neurol"},{"key":"1338_CR6","first-page":"111","volume":"10","author":"A Martin","year":"2014","unstructured":"Martin A, Abogunrin S, Kurth H, Dinet J. Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review. Neuropsychiatr Dis Treat. 2014;10:111\u201322.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"1338_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000091222","volume":"21","author":"AK Welmer","year":"2006","unstructured":"Welmer AK, von Arbin M, Widen Holmqvist L, Sommerfeld DK. Spasticity and its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis. 2006;21(4):247\u201353.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"1338_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pmrj.2016.09.004","volume":"9","author":"S Jorgensen","year":"2017","unstructured":"Jorgensen S, Iwarsson S, Lexell J. Secondary health conditions, activity limitations, and life satisfaction in older adults with long-term spinal cord injury. PM R. 2017;9(4):356\u201366.","journal-title":"PM R"},{"issue":"14","key":"1338_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/09638288.2016.1198432","volume":"39","author":"M Barnes","year":"2017","unstructured":"Barnes M, Kocer S, Murie Fernandez M, Balcaitiene J, Fheodoroff K. An international survey of patients living with spasticity. Disabil Rehabil. 2017;39(14):1428\u201334.","journal-title":"Disabil Rehabil"},{"issue":"Suppl 1","key":"1338_CR10","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.expneurol.2003.08.005","volume":"184","author":"JK Fink","year":"2003","unstructured":"Fink JK. Advances in the hereditary spastic paraplegias. Exp Neurol. 2003;184(Suppl 1):S106\u201310.","journal-title":"Exp Neurol"},{"issue":"2","key":"1338_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gaitpost.2012.12.006","volume":"38","author":"M de Niet","year":"2013","unstructured":"de Niet M, Weerdesteyn V, de Bot ST, van de Warrenburg BP, Geurts AC. Does calf muscle spasticity contribute to postural imbalance? A study in persons with pure hereditary spastic paraparesis. Gait Posture. 2013;38(2):304\u20139.","journal-title":"Gait Posture"},{"issue":"2","key":"1338_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/16501977-1909","volume":"47","author":"M de Niet","year":"2015","unstructured":"de Niet M, de Bot ST, van de Warrenburg BP, Weerdesteyn V, Geurts AC. Functional effects of botulinum toxin type-a treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia. J Rehabil Med. 2015;47(2):147\u201353.","journal-title":"J Rehabil Med"},{"issue":"5","key":"1338_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2340\/16501977-2227","volume":"49","author":"J Nonnekes","year":"2017","unstructured":"Nonnekes J, van Lith B, van de Warrenburg BP, Weerdesteyn V, Geurts ACH. Pathophysiology, diagnostic work-up and management of balance impairments and falls in patients with hereditary spastic paraplegia. J Rehabil Med. 2017;49(5):369\u201377.","journal-title":"J Rehabil Med"},{"issue":"9","key":"1338_CR14","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00415-013-7002-3","volume":"260","author":"J Nonnekes","year":"2013","unstructured":"Nonnekes J, de Niet M, Oude Nijhuis LB, de Bot ST, van de Warrenburg BP, Bloem BR, et al. Mechanisms of postural instability in hereditary spastic paraplegia. J Neurol. 2013;260(9):2387\u201395.","journal-title":"J Neurol"},{"issue":"2","key":"1338_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ene.12839","volume":"23","author":"KR Servelhere","year":"2016","unstructured":"Servelhere KR, Faber I, Saute JA, Moscovich M, D'Abreu A, Jardim LB, et al. Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations. Eur J Neurol. 2016;23(2):408\u201311.","journal-title":"Eur J Neurol"},{"key":"1338_CR16","doi-asserted-by":"crossref","unstructured":"Kerstens H, Satink T, Nijkrake MJ, De Swart BJM, Van Lith BJH, Geurts ACH, et al. Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia. Disabil Rehabil. 2019:1\u20138.","DOI":"10.1080\/09638288.2019.1610084"},{"issue":"2","key":"1338_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sc.2010.61","volume":"49","author":"M Braschinsky","year":"2011","unstructured":"Braschinsky M, Rannikmae K, Krikmann U, Luus SM, Raidvee A, Gross-Paju K, et al. Health-related quality of life in patients with hereditary spastic paraplegia in Estonia. Spinal Cord. 2011;49(2):175\u201381.","journal-title":"Spinal Cord"},{"issue":"1","key":"1338_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13023-016-0469-0","volume":"11","author":"KW Fjermestad","year":"2016","unstructured":"Fjermestad KW, Kanavin OJ, Naess EE, Hoxmark LB, Hummelvoll G. Health survey of adults with hereditary spastic paraparesis compared to population study controls. Orphanet J Rare Dis. 2016;11(1):98.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"1338_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00415-018-9129-8","volume":"266","author":"SA Schneider","year":"2019","unstructured":"Schneider SA, Beckinger VE, Moller B, Knupfer S, Hamann M, Deuschl G. Urinary symptoms, quality of life, and patient satisfaction in genetic and sporadic hereditary spastic paraplegia. J Neurol. 2019;266(1):207\u201311.","journal-title":"J Neurol"},{"issue":"3","key":"1338_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 2013;126(3):307\u201328.","journal-title":"Acta Neuropathol"},{"key":"1338_CR21","doi-asserted-by":"crossref","unstructured":"Shovlin E, Kunkel D. A survey to explore what information, advice and support community-dwelling people with stroke currently receive to manage instability and falls. Disabil Rehabil. 2017:1\u20137.","DOI":"10.1080\/09638288.2017.1376356"},{"issue":"4","key":"1338_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1191\/0269215505cr796oa","volume":"19","author":"SF Mackintosh","year":"2005","unstructured":"Mackintosh SF, Hill K, Dodd KJ, Goldie P, Culham E. Falls and injury prevention should be part of every stroke rehabilitation plan. Clin Rehabil. 2005;19(4):441\u201351.","journal-title":"Clin Rehabil"},{"issue":"3","key":"1338_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ageing\/afn066","volume":"37","author":"A Ashburn","year":"2008","unstructured":"Ashburn A, Hyndman D, Pickering R, Yardley L, Harris S. Predicting people with stroke at risk of falls. Age Ageing. 2008;37(3):270\u20136.","journal-title":"Age Ageing"},{"issue":"2","key":"1338_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/apmr.2002.28030","volume":"83","author":"D Hyndman","year":"2002","unstructured":"Hyndman D, Ashburn A, Stack E. Fall events among people with stroke living in the community: circumstances of falls and characteristics of fallers. Arch Phys Med Rehabil. 2002;83(2):165\u201370.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"1338_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2522\/ptj.20120231","volume":"93","author":"HJ Gunn","year":"2013","unstructured":"Gunn HJ, Newell P, Haas B, Marsden JF, Freeman JA. Identification of risk factors for falls in multiple sclerosis: a systematic review and meta-analysis. Phys Ther. 2013;93(4):504\u201313.","journal-title":"Phys Ther"},{"issue":"7","key":"1338_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/0269215513517575","volume":"28","author":"C Gianni","year":"2014","unstructured":"Gianni C, Prosperini L, Jonsdottir J, Cattaneo D. A systematic review of factors associated with accidental falls in people with multiple sclerosis: a meta-analytic approach. Clin Rehabil. 2014;28(7):704\u201316.","journal-title":"Clin Rehabil"},{"issue":"2","key":"1338_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/17518423.2012.725107","volume":"16","author":"P Morgan","year":"2013","unstructured":"Morgan P, McGinley J. Performance of adults with cerebral palsy related to falls, balance and function: a preliminary report. Dev Neurorehabil. 2013;16(2):113\u201320.","journal-title":"Dev Neurorehabil"},{"issue":"3","key":"1338_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sc.2012.134","volume":"51","author":"LD Facchinetti","year":"2013","unstructured":"Facchinetti LD, Araujo AQ, Chequer GL, de Azevedo MF, de Oliveira RV, Lima MA. Falls in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Spinal Cord. 2013;51(3):222\u20135.","journal-title":"Spinal Cord"},{"issue":"1","key":"1338_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.sc.3101909","volume":"45","author":"SS Brotherton","year":"2007","unstructured":"Brotherton SS, Krause JS, Nietert PJ. Falls in individuals with incomplete spinal cord injury. Spinal Cord. 2007;45(1):37\u201340.","journal-title":"Spinal Cord"},{"issue":"12","key":"1338_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sc.2017.70","volume":"55","author":"NB Finnerup","year":"2017","unstructured":"Finnerup NB. Neuropathic pain and spasticity: intricate consequences of spinal cord injury. Spinal Cord. 2017;55(12):1046\u201350.","journal-title":"Spinal Cord"},{"issue":"1","key":"1338_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/NRE-141196","volume":"36","author":"F Bertolucci","year":"2015","unstructured":"Bertolucci F, Di Martino S, Orsucci D, Ienco EC, Siciliano G, Rossi B, et al. Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia. NeuroRehabilitation. 2015;36(1):93\u20139.","journal-title":"NeuroRehabilitation."},{"key":"1338_CR32","doi-asserted-by":"crossref","unstructured":"van Lith BJH, den Boer JD, van de Warrenburg BPC, Weerdesteyn V, Geurts AC. Functional effects of botulinum toxin type a in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia. J Rehabil Med. 2019.","DOI":"10.2340\/16501977-2556"},{"issue":"2","key":"1338_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mds.21809","volume":"23","author":"MJ Hecht","year":"2008","unstructured":"Hecht MJ, Stolze H, Auf dem Brinke M, Giess R, Treig T, Winterholler M, et al. Botulinum neurotoxin type a injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases. Mov Disord. 2008;23(2):228\u201333.","journal-title":"Mov Disord"},{"issue":"2","key":"1338_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1468-1331.2006.01617.x","volume":"14","author":"M Rousseaux","year":"2007","unstructured":"Rousseaux M, Launay MJ, Kozlowski O, Daveluy W. Botulinum toxin injection in patients with hereditary spastic paraparesis. Eur J Neurol. 2007;14(2):206\u201312.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1338_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jnnp.58.2.232","volume":"58","author":"JW Dunne","year":"1995","unstructured":"Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin a. J Neurol Neurosurg Psychiatry. 1995;58(2):232\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clineuro.2014.05.024","volume":"123","author":"K Margetis","year":"2014","unstructured":"Margetis K, Korfias S, Boutos N, Gatzonis S, Themistocleous M, Siatouni A, et al. Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia. Clin Neurol Neurosurg. 2014;123:142\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1338_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/pri.1999.4.1.68","volume":"4","author":"D Richardson","year":"1999","unstructured":"Richardson D, Thompson AJ. Management of spasticity in hereditary spastic paraplegia. Physiother Res Int. 1999;4(1):68\u201376.","journal-title":"Physiother Res Int"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clineuro.2018.09.027","volume":"174","author":"K Chen","year":"2018","unstructured":"Chen K, Marsh EB. Chronic post-stroke fatigue: it may no longer be about the stroke itself. Clin Neurol Neurosurg. 2018;174:192\u20137.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1\u20132","key":"1338_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2006.07.015","volume":"127","author":"O Hadjimichael","year":"2007","unstructured":"Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007;127(1\u20132):35\u201341.","journal-title":"Pain."},{"key":"1338_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jns.2016.12.061","volume":"374","author":"K Herlofson","year":"2017","unstructured":"Herlofson K, Kluger BM. Fatigue in Parkinson's disease. J Neurol Sci. 2017;374:38\u201341.","journal-title":"J Neurol Sci"},{"issue":"3\u20134","key":"1338_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000375397","volume":"39","author":"RA Harrison","year":"2015","unstructured":"Harrison RA, Field TS. Post stroke pain: identification, assessment, and therapy. Cerebrovasc Dis. 2015;39(3\u20134):190\u2013201.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1338_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/sc.2016.102","volume":"55","author":"HA Anton","year":"2017","unstructured":"Anton HA, Miller WC, Townson AF, Imam B, Silverberg N, Forwell S. The course of fatigue after acute spinal cord injury. Spinal Cord. 2017;55(1):94\u20137.","journal-title":"Spinal Cord"},{"issue":"5","key":"1338_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/jnnp.65.5.693","volume":"65","author":"LN Jensen","year":"1998","unstructured":"Jensen LN, Gerstenberg T, Kallestrup EB, Koefoed P, Nordling J, Nielsen JE. Urodynamic evaluation of patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24. J Neurol Neurosurg Psychiatry. 1998;65(5):693\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1338_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-018-0804-8","volume":"13","author":"OJ Kanavin","year":"2018","unstructured":"Kanavin OJ, Fjermestad KW. Gastrointestinal and urinary complaints in adults with hereditary spastic paraparesis. Orphanet J Rare Dis. 2018;13(1):58.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1338-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1338-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1338-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T19:47:19Z","timestamp":1614800839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1338-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1338-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the regional medical ethics committee \u201cCommissie Mensgebonden Onderzoek Arnhem-Nijmegen\u201d (number 2016\u20132922) and conducted according to the declaration of Helsinki. All participants were adults who consented to participate with written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}